Welcome to the 3rd Epigenetic–Targeted Drug Discovery & Development Summit
Taking place in person for the first time this summer, the 3rd Annual Epigenetic-Targeted Drug Discovery & Development Summit is the first and only devoted industry-specific forum exclusively focused on showcasing the latest research and pre-clinical and translational development of small-molecule, and other epigenetic modulators of gene expression, whilst providing pivotal insights to kickstart the next generation of clinically defining therapeutics and help overcome early-stage clinical trial challenges.
Attendees can expect to hear the latest discovery, preclinical and translational advancements in therapeutic interventions targeting all areas of epigenetic machinery including DNA methylation, histone post-translational modifications, chromatin remodeling, and non-coding RNAs (ncRNAs).
Access the full event guide to learn more.
2022 World-Class Speaker Faculty:
Director of Drug Discovery
Vice President Biological Sciences
Chief Scientific Officer
Assistant Director for Center for Functional Cancer Epigenetics
Dana-Farber Cancer Institute
Co-Founder & Chief Scientific Officer